Advanced Biomed Inc Other Significant Noncash Transaction, Value of Consideration Received
Advanced Biomed Inc (ADVB) reported Other Significant Noncash Transaction, Value of Consideration Received of $448 for the 3-month period ending 2025-09-30, per its 10-Q filed 2025-11-19.
Financial Statements › Cash Flow › Operating Activities
us-gaap:OtherSignificantNoncashTransactionValueOfConsiderationReceived1 · last filed 2025-11-19
- Advanced Biomed Inc other significant noncash transaction, value of consideration received for the quarter ending 2025-09-30 was $448.00, a 4380.00% increase year-over-year.
- Advanced Biomed Inc other significant noncash transaction, value of consideration received for the quarter ending 2024-09-30 was $10.00.
- Advanced Biomed Inc other significant noncash transaction, value of consideration received for fiscal 2025 was $24.91K.
| Period end | Other Significant Noncash Transaction, Value of Consideration Received 3 month | Other Significant Noncash Transaction, Value of Consideration Received 12 month |
|---|---|---|
| 2025-09-30 | $448.00 10-Q · filed 2025-11-19 | |
| 2025-06-30 | $24.91K 10-K · filed 2025-10-08 | |
| 2024-09-30 | $10.00 10-Q · filed 2025-11-19 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |
| Aclarion, Inc. (ACON) | United States | $0.008B | |
| BioNexus Gene Lab Corp (BGLC) | $0.004B | ||
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| BIODESIX INC (BDSX) | United States | $0.312B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |